SynBiotic SE
SynBiotic SE
NuWays RecommendationRecommendation
Buy
Price Target
€9.00
Upside
51.52%
Chart
- 1M
- 3M
- 6M
- YTD
- 1Y
- 3Y
€5.94
(€0.18) (-2.94%)
Realtime-Data from 16.09.2024 15:44:15
SynBiotic is a German Buy-and-Build cannabis platform company focusing on pharmaceuticals and dietary supplements, as well as on the research and development of new solutions based on cannabinoids and terpenes. The company covers the entire value chain. SynBiotic is continuously expanding its presence in all market sectors. Although the company's origins are in the wellness and food markets, SynBiotic has set itself the goal of fully exploiting the potential of the medical markets.
Ticker
SBX GY
Market Cap
€31.07 M
Enterprise Value
€33.85 M
26 week avg vol.
13500
Primar Exchange
Xetra
IPO
2019
Sector
Health Care & Pharma
Headquarters
München, DE
Employees
104
Incorporated
2015
CEO
Daniel Kruse
Website
Management & Founders
63.00%
Other institutional investors
26.00%
Free Float
11.00%
31.05.2024
Publication of annual report
30.06.2024
Annual General Meeting
30.09.2024
Publication half yearly financial report
KPIs in EUR
KPI | 2022 | 2023e | 2024e |
---|---|---|---|
Sales | 8.17 M | 11.27 M | 13.51 M |
EBITDA | (7.41 M) | (2.98 M) | (1.83 M) |
EBIT | (25.92 M) | (3.95 M) | (2.91 M) |
EPS | (5.47) | (0.48) | (0.44) |
FCF | (7.44 M) | (4.41 M) | (2.00 M) |
Valuation
KPI | 2022 | 2023e | 2024e |
---|---|---|---|
EV / Sales | 4.15x | 3.01x | 2.66x |
EV / EBITDA | (4.57x) | (11.39x) | (19.64x) |
EV / EBIT | (1.31x) | (8.57x) | (12.35x) |
Price / Earnings | (1.08x) | (12.25x) | (13.61x) |
EV / FCF | (4.55x) | (7.68x) | (17.97x) |
Downloads
Latest Research